Leucine to proline substitution by SNP at position 197 in Caspase-9 gene expression leads to neuroblastoma: A bioinformatics analysis

3 Biotech

Volumn 3, Issue 3, 2013, Pages 225-234

  Kundu, Arpita ^a   Bag, Susmita ^a   Ramaiah, Sudha ^a   Anbarasu, Anand ^a  

^a VIT UNIVERSITY   (India)

Author keywords

CASP9; Leucine; Neuroblastoma; Proline; Rs1052574

Indexed keywords

CASPASE 9; LEUCINE; PROLINE;

ALGORITHM; AMINO ACID SUBSTITUTION; APOPTOSIS; ARTICLE; BIOINFORMATICS; GENE EXPRESSION; HYDROGEN BOND; MUTATION; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN STABILITY; REGULATORY SEQUENCE; RNA SPLICING; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 85200168761     PISSN: 2190572X     EISSN: 21905738     Source Type: Journal    
DOI: 10.1007/s13205-012-0088-y     Document Type: Article

References (65)

1. Abel F, Sjoberg R-M, Ejeska K et al (2002) Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours. Br J Cancer 86:596-604.
2. Abel F, Sjoberg R-M, Nilsson S et al (2005) Imbalance of the mitochondrial pro-and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology. Eur J Cancer 41:635-646.
3. Ashkenazy H, Erez E, Martz E et al (2010) ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res 38:529-533.
4. Bao L, Cui Y (2005) Prediction of the phenotypic effects of nonsynonymous single nucleotide polymorphisms using structural and evolutionary information. Bioinformatics 21:2185-2190.
5. Bao L, Zhou M, Cui Y (2005) nsSNPAnalyzer: identifying diseaseassociated nonsynonymous single nucleotide polymorphisms. Nucleic Acids Res 33:480-482.
6. Bowie JU, Luthy R, Eisenberg D (1991) A method to identify protein sequences that fold into a known three-dimensional structure. Science 253:164-170.
7. Brodeur GM, Azar C, Brother M et al (1992) Neuroblastoma. Cancer 70:1685-1694.
8. Cartegni L, Wang J, Zhu Z et al (2003) ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31:3568-3571.
9. Cattelani S, Defferrari R, Marsilio S et al (2008) Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients. Clin Cancer Res 14:3248-3253.
10. Cordes MH, Sauer RT (1999) Tolerance of a protein to multiple polar-to-hydrophobic surface substitutions. Protein Sci 8:318-325.
11. Eswar N, Webb B, Renom MAM et al (2007) Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci 2(9):1-31.
12. Fairbrother WG, Yeo RF, Sharp PA et al (2002) Predictive identification of exonic splicing enhancers in human genes. Science 297:1007-1013.
13. Fairbrother WG, Yeo GW, Yeh R et al (2004) RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons. Nucleic Acids Res 32:187-190.
14. Fisher A, Sali A (2003) Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol 374:461-491.
15. Gale GB, D'Angio GJ, Uri A et al (1982) Cancer in neonates: the experience at the Children's Hospital of Philadelphia. Pediatrics 70:409-413.
16. Gerken T, Tep C, Rarick J (2004) The role of peptide sequence and neighboring residue glycosylation on the substrate specificity of the uridine 50-diphosphate-alpha-nacetylgalactosamine: polypeptide N-acetylgalactosaminyl transferases T1 and T2: kinetic modeling of the porcine and canine submaxillary gland mucin tandem repeats. Biochemistry 43:9888-9900.
17. Gidalevitz T, Krupinski T, Garcia S et al (2009) Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity. PLoS Genet 5:399-498.
18. Glaser F, Pupko T, Paz I et al (2003) ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 19:163-164.
19. Goldenberg O, Erez E, Nimrod G, Ben-Tal N (2009) The ConSurf-DB: pre-calculated evolutionary conservation profiles of protein structures. Nucleic Acids Res 37:323-327.
20. Greenblatt MS, Beaudet JG, Gump JR et al (2003) Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants. Oncogene 22:1150-1163.
21. Guerois R, Nielsen JE, Serrano L (2002) Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J Mol Biol 320:369-387.
22. Guex N (1996) Swiss-PdbViewer: a new fast and easy to use PDB viewer for the Macintosh. Experientia 52:A26.
23. Guex N, Peitsch MC (1996) Swiss-PdbViewer: a fast and easy-to-use PDB viewer for Macintosh and PC. Protein Data Bank Q Newslett 77:7.
24. Heinrichs S, Look AT (2007) Identification of structural aberrations in cancer by SNP array analysis. Genome Biol 8:219.1-219.5.
25. Huang T, Wang P, Ye ZQ et al (2010) Prediction of deleterious nonsynonymous SNPs based on protein interaction network and hybrid properties. PLoS ONE 5:11900-11907.
26. Hubbard TJP, Aken BL, Ayling S et al (2009) Ensembl 2009. Nucleic Acids Res 37:690-697.
27. Johnson MM, Houck J, Chen C (2005) Screening for deleterious nonsynonymous single-nucleotide polymorphisms in genes involved in steroid hormone metabolism and response. Cancer Epidemiol Biomark Prev 4:1326-1329.
28. Karchin R, Diekhans M, Kelly L et al (2005) LS-SNP: large-scale annotation of coding non-synonymous SNPs based on multiple information sources. Bioinformatics 21:2814-2820.
29. Kato GJ (1999) Human genetic diseases of proteolysis. Hum Mutat 13:87-98.
30. Khan S, Vihinen M (2007) Spectrum of disease-causing mutations in protein secondary structures. BMC Struct Biol 7:56-74.
31. Kortemmea T, Morozova AV, Baker D (2003) An orientation dependent hydrogen bonding potential improves prediction of specificity and structure for proteins and protein-protein complexes. J Mol Biol 326:1239-1259.
32. Kuhn R, Karolchik D, Zweig AS et al (2007) The UCSC genome browser database: update 2007. Nucleic Acids Res 35:668-673.
33. Lanver D, Mendoza-Mendoza A, Brachmann A et al (2010) Sho1 and Msb2-related proteins regulate appressorium development in the smut fungus Ustilago maydis. Plant Cell 22:2085-2101.
34. Lastowska M, Cullinane C, Variend S et al (2001) Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors. J Clin Oncol 19:3080-3090.
35. Lee PH, Shatkay H (2008) F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 36:820-824.
36. Lee PH, Shatkay H (2009) An integrative scoring system for ranking SNPs by their potential deleterious effects. Bioinformatics 25:1048-1055.
37. Li S-C, Goto NK, Williams KA et al (1996) α-Helical, but not b-sheet, propensity of proline is determined by peptide environment. Biochemistry 93:6676-6681.
38. Liaoa PY, Lee KH (2010) From SNPs to functional polymorphism: the insight into biotechnology applications. Biochem Eng J 49:149-158.
39. Mah JTL, Low ESH, Lee E (2011) In silico SNP analysis and bioinformatics tools: a review of the state of the art to aid drug discovery. Drug Discov Today 16:800-809.
40. Moore DJ, Zhang L, Dawson TM et al (2003) A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo oligomerization. J Neurochem 87:1558-1567.
41. Ng P, Henikoff S (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31:3812-3814.
42. Ohira M, Kageyama H, Mihara M et al (2000) Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line. Oncogene 19:4302-4307.
43. Querol E, Perez-Pons JA, Mozo-Vularias A (1996) Analysis of protein conformational characteristics related to thermostability. Protein Eng 9:265-271.
44. Ramensky V, Bork P, Sunyaev S (2002) Human nonsynonymous SNPs: server and survey. Nucleic Acids Res 30:3894-3900.
45. Reumers J, Schymkowitz J, Ferkinghoff-Borg J et al (2005) SNPeffect: a database mapping molecular phenotypic effects of human non-synonymous coding SNPs. Nucleic Acids Res 33:527-532.
46. Reumers J, Maurer-Stroh S, Schymkowitz J et al (2006) SNPeffect v2.0: a new step in investigating the molecular phenotypic effects of human non-synonymous SNPs. Bioinformatics 22:2183-2185.
47. Ryan M, Diekhans M, Lien S et al (2009) LS-SNP/PDB: annotated non-synonymous SNPs mapped to Protein Data Bank structures. Bioinformatics 25:1431-1432.
48. Schor NF (1999) Neuroblastoma as a neurobiological disease. J Neurooncol 41:159-166.
49. Schymkowitz J, Borg J, Stricher F et al (2005) The FoldX web server: an online force field. Nucleic Acids Res 33:382-388.
50. Shen J, Deininger PL, Zhao H (2006) Applications of computational algorithm tools to identify functional SNPs in cytokine genes. Cytokine 35:62-66.
51. Shojaei-Brosseau T, Chompret A, Abel A et al (2004) Genetic epidemiology of neuroblastoma: a study of 426 cases at the Institute Gustave-Roussy in France. Pediatr Blood Cancer 42:99-105.
52. Shortle S, Sondek J (1995) The emerging role of insertions and deletions in protein engineering. Curr Opin Biotechnol 6:387-393.
53. Smith PJ, Zhang C, Wang J et al (2006) An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet 15:2490-2508.
54. Soengas MS, Alarcon RM, Yoshida H et al (1999) Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284:156-159.
55. Suh Y, Vijg J (2005) SNP discovery in associating genetic variation with human disease phenotypes. Mutat Res 573:41-53.
56. Sunyaev S, Ramanesky V, Bork P (2000) Towards a structural basis of human non-synonymous single nucleotide polymorphisms. Trends Genet 16:198-200.
57. Vu PK, Sakamoto KM (2000) Ubiquitin-mediated protein degradation in genetic diseases proteolysis and human disease. Mol Genet Metab 71:261-266.
58. Wang Z, Moult J (2001) SNPs, protein structure, and disease. Hum Mutat 17:263-270.
59. Waters PJ (2001) Degradation of mutant proteins, underlying "loss of function" phenotypes, plays a major role in genetic disease. Curr Issues Mol Biol 3:57-65.
60. Wheeler DL, Barrett T, Benson DA et al (2008) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 36:13-21.
61. Williamson MP (1994) The structure and function of proline-rich regions in proteins. Biochem J 297:249-260.
62. Yue P, Melamud E, Moult J (2006) SNPs3D: candidate gene and SNP selection for association studies. BMC Bioinformatics 7:166-181.
63. Zhang XHF, Kangsamaksin T, Chao MSP et al (2005) Exon inclusion is dependent on predictable exonic splicing enhancers. Mol Cell Biol 25:7323-7332.
64. Zhivotovsky B, Orrenius S (2006) Carcinogenesis and apoptosis: paradigms and paradoxes. Carcinogenesis 27:1939-1945.
65. Zhu Y, Hoffman A, Wu X et al (2008) Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools. Mutat Res 639:80-88.